RecruitingPhase 2NCT07275515

DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Lille
Intervention
DRF(drug)
Enrollment
192 target
Eligibility
18 years · All sexes
Timeline
20262029

Study locations (1)

Collaborators

Ministère de la Santé

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07275515 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome

← Back to all trials